Lemon Tree Hotels Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 8, 2025, 3:04 am

Competitors of Lemon Tree Hotels Ltd

All Competitor Stocks of Lemon Tree Hotels Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:45 am

Below is a detailed analysis of the quarterly data for Lemon Tree Hotels Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 316.00 Cr.. The value appears to be declining and may need further review. It has decreased from 379.00 Cr. (Mar 2025) to 316.00 Cr., marking a decrease of 63.00 Cr..
• For Expenses, as of Jun 2025, the value is 176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 175.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 1.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 140.00 Cr.. The value appears to be declining and may need further review. It has decreased from 203.00 Cr. (Mar 2025) to 140.00 Cr., marking a decrease of 63.00 Cr..
• For OPM %, as of Jun 2025, the value is 44.00%. The value appears to be declining and may need further review. It has decreased from 54.00% (Mar 2025) to 44.00%, marking a decrease of 10.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 45.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 47.00 Cr. (Mar 2025) to 45.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 34.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 35.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 122.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 59.00 Cr..
• For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 12.00% (Mar 2025) to 23.00%, marking an increase of 11.00%.
• For Net Profit, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 108.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 60.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.48. The value appears to be declining and may need further review. It has decreased from 1.07 (Mar 2025) to 0.48, marking a decrease of 0.59.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:56 pm

Growth

Last Updated: September 5, 2025, 9:40 am

Balance Sheet

Last Updated: October 10, 2025, 2:26 pm

Below is a detailed analysis of the balance sheet data for Lemon Tree Hotels Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 792.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 792.00 Cr..
• For Reserves, as of Mar 2025, the value is 372.00 Cr.. The value appears strong and on an upward trend. It has increased from 175.00 Cr. (Mar 2024) to 372.00 Cr., marking an increase of 197.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,148.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 2,336.00 Cr. (Mar 2024) to 2,148.00 Cr., marking a decrease of 188.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 763.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 725.00 Cr. (Mar 2024) to 763.00 Cr., marking an increase of 38.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,075.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,028.00 Cr. (Mar 2024) to 4,075.00 Cr., marking an increase of 47.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 3,556.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,641.00 Cr. (Mar 2024) to 3,556.00 Cr., marking a decrease of 85.00 Cr..
• For CWIP, as of Mar 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2024) to 59.00 Cr., marking an increase of 34.00 Cr..
• For Investments, as of Mar 2025, the value is 45.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 45.00 Cr., marking an increase of 32.00 Cr..
• For Other Assets, as of Mar 2025, the value is 415.00 Cr.. The value appears strong and on an upward trend. It has increased from 348.00 Cr. (Mar 2024) to 415.00 Cr., marking an increase of 67.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,075.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,028.00 Cr. (Mar 2024) to 4,075.00 Cr., marking an increase of 47.00 Cr..

However, the Borrowings (2,148.00 Cr.) are higher than the Reserves (372.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Lemon Tree Hotels Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 5. It has increased from 1.88 (Mar 24) to 2.48, marking an increase of 0.60.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 5. It has increased from 1.88 (Mar 24) to 2.48, marking an increase of 0.60.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.83. This value is within the healthy range. It has increased from 3.70 (Mar 24) to 4.83, marking an increase of 1.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.69. It has decreased from 19.53 (Mar 24) to 14.69, marking a decrease of 4.84.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.69. It has decreased from 19.53 (Mar 24) to 14.69, marking a decrease of 4.84.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 16.24. It has increased from 13.53 (Mar 24) to 16.24, marking an increase of 2.71.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.04. This value is within the healthy range. It has increased from 6.68 (Mar 24) to 8.04, marking an increase of 1.36.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.28. This value is within the healthy range. It has increased from 5.26 (Mar 24) to 6.28, marking an increase of 1.02.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.74. This value is within the healthy range. It has increased from 2.72 (Mar 24) to 3.74, marking an increase of 1.02.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.07. This value is within the healthy range. It has increased from 2.29 (Mar 24) to 3.07, marking an increase of 0.78.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.48. This value is within the healthy range. It has increased from 1.88 (Mar 24) to 2.48, marking an increase of 0.60.
• For PBDIT Margin (%), as of Mar 25, the value is 49.48. This value is within the healthy range. It has increased from 49.37 (Mar 24) to 49.48, marking an increase of 0.11.
• For PBIT Margin (%), as of Mar 25, the value is 38.65. This value exceeds the healthy maximum of 20. It has decreased from 38.90 (Mar 24) to 38.65, marking a decrease of 0.25.
• For PBT Margin (%), as of Mar 25, the value is 23.05. This value is within the healthy range. It has increased from 20.08 (Mar 24) to 23.05, marking an increase of 2.97.
• For Net Profit Margin (%), as of Mar 25, the value is 18.92. This value exceeds the healthy maximum of 10. It has increased from 16.89 (Mar 24) to 18.92, marking an increase of 2.03.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.28. This value is within the healthy range. It has increased from 13.86 (Mar 24) to 15.28, marking an increase of 1.42.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.89. This value is within the healthy range. It has increased from 15.35 (Mar 24) to 16.89, marking an increase of 1.54.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.30. This value is within the healthy range. It has increased from 11.34 (Mar 24) to 13.30, marking an increase of 1.96.
• For Return On Assets (%), as of Mar 25, the value is 4.81. This value is below the healthy minimum of 5. It has increased from 3.68 (Mar 24) to 4.81, marking an increase of 1.13.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.66. This value exceeds the healthy maximum of 1. It has decreased from 1.73 (Mar 24) to 1.66, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.85. This value exceeds the healthy maximum of 1. It has decreased from 1.95 (Mar 24) to 1.85, marking a decrease of 0.10.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.31. It has increased from 0.27 (Mar 24) to 0.31, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1.5. It has increased from 0.57 (Mar 24) to 0.85, marking an increase of 0.28.
• For Quick Ratio (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has increased from 0.53 (Mar 24) to 0.81, marking an increase of 0.28.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.51. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 5.51, marking an increase of 5.51.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.17. This value is within the healthy range. It has increased from 2.62 (Mar 24) to 3.17, marking an increase of 0.55.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 3. It has increased from 1.90 (Mar 24) to 2.21, marking an increase of 0.31.
• For Enterprise Value (Cr.), as of Mar 25, the value is 12,868.30. It has increased from 12,768.29 (Mar 24) to 12,868.30, marking an increase of 100.01.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.01. This value exceeds the healthy maximum of 3. It has decreased from 11.92 (Mar 24) to 10.01, marking a decrease of 1.91.
• For EV / EBITDA (X), as of Mar 25, the value is 20.22. This value exceeds the healthy maximum of 15. It has decreased from 24.14 (Mar 24) to 20.22, marking a decrease of 3.92.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.91. This value exceeds the healthy maximum of 3. It has decreased from 9.67 (Mar 24) to 7.91, marking a decrease of 1.76.
• For Price / BV (X), as of Mar 25, the value is 8.75. This value exceeds the healthy maximum of 3. It has decreased from 10.71 (Mar 24) to 8.75, marking a decrease of 1.96.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.91. This value exceeds the healthy maximum of 3. It has decreased from 9.67 (Mar 24) to 7.91, marking a decrease of 1.76.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness